Skip to main content

Acquired Brain Injury

0
Pipeline Programs
4
Companies
5
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

ETS
ETSMO - Rolla
2 programs
ErigoBasic or ErigoPro®N/A1 trial
Free Aspire with Expiratory Flow AcceleratorN/A1 trial
Active Trials
NCT06469983Recruiting118Est. Nov 2026
NCT05993364Unknown20Est. Dec 2025
FUJIFILM Pharma
FUJIFILM PharmaMA - Cambridge
1 program
Cognitive Computerized TrainingN/A1 trial
Active Trials
NCT06130735Active Not Recruiting30Est. Sep 2026
Libra Therapeutics
Libra TherapeuticsCA - San Diego
1 program
LibraVRN/A1 trial
Active Trials
NCT05052905Completed2Est. Apr 2023
Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
1 program
Multifaceted implementation programN/A1 trial
Active Trials
NCT07375485Enrolling By Invitation20Est. Jun 2027

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
Colorado TherapeuticsMultifaceted implementation program
ETSErigoBasic or ErigoPro®
ETSFree Aspire with Expiratory Flow Accelerator
FUJIFILM PharmaCognitive Computerized Training
Libra TherapeuticsLibraVR

Clinical Trials (5)

Total enrollment: 190 patients across 5 trials

NCT07375485Colorado TherapeuticsMultifaceted implementation program

Occupational Therapy for Mental Health and Engagement in Neurorehabilitation

Start: Jul 2025Est. completion: Jun 202720 patients
N/AEnrolling By Invitation
NCT06469983ETSErigoBasic or ErigoPro®

Robotic vs. Traditional Verticalization in Patients With Severe Acquired Brain Injury: a Randomized Controlled Trial

Start: Dec 2024Est. completion: Nov 2026118 patients
N/ARecruiting
NCT05993364ETSFree Aspire with Expiratory Flow Accelerator

Efficacy of EFA in Acquired Brain Injury

Start: Feb 2024Est. completion: Dec 202520 patients
N/AUnknown
NCT06130735FUJIFILM PharmaCognitive Computerized Training

Impact of Intensive Computerized Cognitive Training

Start: Oct 2023Est. completion: Sep 202630 patients
N/AActive Not Recruiting
NCT05052905Libra TherapeuticsLibraVR

VR-based Remote Rehabilitation for Pediatric ABI

Start: Oct 2021Est. completion: Apr 20232 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 190 patients
4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.